Fundraising FoxGolgenia
1 known investors
Find your way into Golgenia
Sign up to see every warm intro you have to Golgenia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Golgenia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Golgenia is a biotech startup developing small-molecule inhibitors that target Golgi-based "glyco-oncogenes" — proteins that disrupt glycosylation and drive tumor development. Its research aims to create anticancer therapies, including for tumors that are non-responsive to current treatments, with an initial drug series acting on glycosphingolipid biosynthesis.
Founders & leadership
AL
Alberto LuiniProfessor / Scientific Founder
Investors · 1
Frequently asked questions
- What does Golgenia do?
- Golgenia is a biotech startup developing small-molecule inhibitors that target Golgi-based "glyco-oncogenes" — proteins that disrupt glycosylation and drive tumor development. Its research aims to create anticancer therapies, including for tumors that are non-responsive to current treatments, with an initial drug series acting on glycosphingolipid biosynthesis.
- Who are Golgenia's investors?
- Golgenia's investors include Indaco Venture Partners.